Literature DB >> 17848285

Established and emerging concepts in epidermal growth factor receptor biology.

Jennifer R Grandis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17848285     DOI： 10.1016/j.ijrobp.2007.05.040

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  4 in total

1.  Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer.

Authors:  Wei Yang; Quan Cai; Vivian W Y Lui; Patrick A Everley; Jayoung Kim; Neil Bhola; Kelly M Quesnelle; Bruce R Zetter; Hanno Steen; Michael R Freeman; Jennifer R Grandis
Journal:  J Proteome Res       Date:  2010-06-04       Impact factor: 4.466

2.  Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study.

Authors:  Hui-Ching Wang; Pei-Lin Liu; Pei-Chuan Lo; Yi-Tzu Chang; Leong-Perng Chan; Tsung-Jang Yeh; Hui-Hua Hsiao; Shih-Feng Cho
Journal:  PeerJ       Date:  2020-09-10       Impact factor: 2.984

3.  PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.

Authors:  Wei-Chiao Chang; Shuo-Lun Wu; Wan-Chen Huang; Jinn-Yuan Hsu; Shih-Hung Chan; Ju-Ming Wang; Jhih-Peng Tsai; Ben-Kuen Chen
Journal:  Oncotarget       Date:  2015-04-10

4.  Cetuximab: its unique place in head and neck cancer treatment.

Authors:  Pol Specenier; Jan B Vermorken
Journal:  Biologics       Date:  2013-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.